These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 8140762)

  • 1. [Adverse effects of interferon alfa].
    Adam Z
    Vnitr Lek; 1994 Feb; 40(2):127-9. PubMed ID: 8140762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Side effects of alpha interferon in chronic hepatitis C.
    Dusheiko G
    Hepatology; 1997 Sep; 26(3 Suppl 1):112S-121S. PubMed ID: 9305675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Psychotic disorders induced by interferon alfa].
    D'Innella P; Zaccala G; Terazzi M; Olgiati P; Torre E
    Recenti Prog Med; 2002 Jun; 93(6):367-9. PubMed ID: 12085716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment with interferon and autoimmunity].
    Gaja A; Franková H; Kocák I; Slapnicková J; Hejlová N
    Vnitr Lek; 1999 Jul; 45(7):409-13. PubMed ID: 11045159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
    Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quality of life and tolerance of maintenance therapy in patients with multiple myeloma].
    Adam Z; Pour L; Svobodník A; Scudla V; Salajka F; Vytrasová M; Bacovský J; Schützová M; Koza V; Sumná E; Franková H; Lehanka F; Gumulec J; Stavarová Y; Cahová S; Vránová M; Dostálová V; Kessler P; Walterová L; Meluzínová I; Seifertová N; Sláma O; Büchler T; Krejcí M; Bencíková V; Nykodýmová V; Dusek L; Hájek R;
    Vnitr Lek; 2002 Mar; 48(3):216-29. PubMed ID: 11968583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypocalcemia and azotemia associated with zoledronic acid and interferon alfa.
    Tanvetyanon T; Choudhury AM
    Ann Pharmacother; 2004 Mar; 38(3):418-21. PubMed ID: 14970365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Occurrence of autoimmune complications in patients with chronic myelocytic leukemia during treatment with interferon alfa].
    Tóthová E; Stecová N; Kafková A; Fricová M; Svorcová E
    Vnitr Lek; 2002 May; 48(5):380-3. PubMed ID: 12061203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life-threatening severe immune thrombocytopenia during alpha-interferon therapy for chronic hepatitis C.
    Fujii H; Kitada T; Yamada T; Sakaguchi H; Seki S; Hino M
    Hepatogastroenterology; 2003; 50(51):841-2. PubMed ID: 12828100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interferon-alpha. Results of a pharmaco-epidemiologic study].
    Grion AM; Gaion RM; Cordella L; Bano F; Cannada RA; Innamorati G; Berti T
    Clin Ter; 1994 Mar; 144(3):201-11. PubMed ID: 8181216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic hepatitis B: a wider range of therapeutic options.
    Prescrire Int; 2007 Aug; 16(90):157-62. PubMed ID: 17724844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of hypertriglyceridemia in patients receiving interferon for malignant melanoma.
    Wong SF; Jakowatz JG; Taheri R
    Ann Pharmacother; 2004 Oct; 38(10):1655-9. PubMed ID: 15304625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C: limits and dose regimen of interferon alfa.
    Prescrire Int; 1998 Oct; 7(37):150-4. PubMed ID: 10915423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interferon-alpha and PUVA therapy for mycosis fungoides].
    Marschalkó M; Kovács J; Somlai B; Berecz M; Hídvégi B; Hársing J; Désaknai M; Horváth A
    Orv Hetil; 2001 Sep; 142(37):2021-3. PubMed ID: 11582733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anemia in patients with midgut carcinoid, treated with alpha interferon: effects by erythropoietin treatment on the perceived quality of life.
    Larsson G; Janson ET
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):200-4. PubMed ID: 18302658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irritability rather than depression during interferon treatment is linked to increased tryptophan catabolism.
    Russo S; Kema IP; Haagsma EB; Boon JC; Willemse PH; den Boer JA; de Vries EG; Korf J
    Psychosom Med; 2005; 67(5):773-7. PubMed ID: 16204437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuropsychiatric symptoms related to interferon alpha].
    Małyszczak K; Inglot M; Pawłowski T; Czarnecki M; Rymer W; Kiejna A
    Psychiatr Pol; 2006; 40(4):787-97. PubMed ID: 17068950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Seizures during interferon alpha therapy: three cases in dermatology].
    Legroux-Crespel E; Lafaye S; Mahé E; Picard-Dahan C; Crickx B; Sassolas B; Descamps V
    Ann Dermatol Venereol; 2003 Feb; 130(2 Pt 1):202-4. PubMed ID: 12671585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial.
    Sostegni R; Ghisetti V; Pittaluga F; Marchiaro G; Rocca G; Borghesio E; Rizzetto M; Saracco G
    Hepatology; 1998 Aug; 28(2):341-6. PubMed ID: 9695995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The retreatment with natural leukocyte interferon alfa-n3 of chronic hepatitis C patients: the intolerant and nonresponsive results to prior treatment with recombinant alfa interferon].
    Cagnoni C; Pancotti D; Carrara G
    Ann Ital Med Int; 1999; 14(3):159-65. PubMed ID: 10566181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.